Amelia Compagni

2.2k total citations
40 papers, 1.7k citations indexed

About

Amelia Compagni is a scholar working on General Health Professions, Economics and Econometrics and Molecular Biology. According to data from OpenAlex, Amelia Compagni has authored 40 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in General Health Professions, 9 papers in Economics and Econometrics and 8 papers in Molecular Biology. Recurrent topics in Amelia Compagni's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Management and Organizational Studies (5 papers) and Public Policy and Administration Research (4 papers). Amelia Compagni is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Management and Organizational Studies (5 papers) and Public Policy and Administration Research (4 papers). Amelia Compagni collaborates with scholars based in Italy, United Kingdom and Austria. Amelia Compagni's co-authors include Gerhard Christofori, Ralf H. Adams, Matthew Cotten, Malcolm Logan, Rüdiger Klein, Valentina Mele, Stefan Weitzer, Petra Wilgenbus, Per Henrik Lindblom and Daniel Zicha and has published in prestigious journals such as Cell, The Journal of Cell Biology and Academy of Management Journal.

In The Last Decade

Amelia Compagni

38 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amelia Compagni Italy 16 904 333 223 180 169 40 1.7k
Zubin Master United States 25 978 1.1× 72 0.2× 112 0.5× 308 1.7× 220 1.3× 93 2.2k
Paul D. Crowe United States 29 887 1.0× 178 0.5× 56 0.3× 376 2.1× 235 1.4× 53 3.2k
Fiona Murray United States 31 1.8k 2.0× 295 0.9× 634 2.8× 302 1.7× 195 1.2× 97 3.7k
Sandra Davis Australia 14 457 0.5× 62 0.2× 117 0.5× 224 1.2× 411 2.4× 24 1.7k
Pauline Wong Australia 22 621 0.7× 129 0.4× 597 2.7× 62 0.3× 40 0.2× 46 2.0k
Hong Ping Zhang China 23 517 0.6× 288 0.9× 25 0.1× 103 0.6× 124 0.7× 70 4.1k
Robin Roberts United States 26 470 0.5× 120 0.4× 37 0.2× 259 1.4× 76 0.4× 82 1.7k
Qingjie Xia China 21 395 0.4× 139 0.4× 41 0.2× 104 0.6× 151 0.9× 83 1.5k
David P. Cook Canada 20 890 1.0× 77 0.2× 171 0.8× 275 1.5× 183 1.1× 63 1.9k
Yong‐Man Kim South Korea 38 934 1.0× 482 1.4× 61 0.3× 739 4.1× 224 1.3× 235 4.9k

Countries citing papers authored by Amelia Compagni

Since Specialization
Citations

This map shows the geographic impact of Amelia Compagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelia Compagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelia Compagni more than expected).

Fields of papers citing papers by Amelia Compagni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelia Compagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelia Compagni. The network helps show where Amelia Compagni may publish in the future.

Co-authorship network of co-authors of Amelia Compagni

This figure shows the co-authorship network connecting the top 25 collaborators of Amelia Compagni. A scholar is included among the top collaborators of Amelia Compagni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelia Compagni. Amelia Compagni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cappellaro, Giulia, et al.. (2025). Conceptualisation and measurement of healthy ageing: Insights from a systematic literature review. Social Science & Medicine. 374. 117933–117933. 2 indexed citations
2.
Cappellaro, Giulia, et al.. (2025). Adoption of artificial intelligence applications in clinical practice: Insights from a Survey of Healthcare Organizations in Lombardy, Italy. Digital Health. 11. 609999392–609999392. 2 indexed citations
3.
4.
Compagni, Amelia, et al.. (2024). Implementation of Machine Learning Applications in Health Care Organizations: Systematic Review of Empirical Studies. Journal of Medical Internet Research. 26. e55897–e55897. 12 indexed citations
5.
6.
Cappellaro, Giulia, et al.. (2023). Implementation of Machine Learning Applications in Health Care Organizations: Protocol for a Systematic Review of Empirical Studies. JMIR Research Protocols. 12. e47971–e47971. 3 indexed citations
7.
Compagni, Amelia, et al.. (2023). Unpacking hybridity: Development and first validation of a multidimensional instrument to profile hybrid professionals. Public Administration. 102(2). 519–539. 3 indexed citations
8.
Castelli, Adriana, Oriana Ciani, Amelia Compagni, et al.. (2021). Corona-regionalism? Differences in regional responses to COVID-19 in Italy. Health Policy. 125(9). 1179–1187. 30 indexed citations
9.
Compagni, Amelia, Patrizio Armeni, & Stefano Tasselli. (2017). When peers count: The effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams. Health Care Management Review. 44(1). 67–78. 6 indexed citations
10.
Cavazza, Marianna, et al.. (2015). I registri in sanità e la creazione di conoscenza: dai database alla produzione scientifica. 16(3). 168–176. 1 indexed citations
11.
Compagni, Amelia, Alessia Melegaro, & Rosanna Tarricone. (2013). Genetic Screening for the Predisposition to Venous Thromboembolism: A Cost-Utility Analysis of Clinical Practice in the Italian Health Care System. Value in Health. 16(6). 909–921. 11 indexed citations
12.
Fantini, Maria Pia, et al.. (2012). General practitioners’ adherence to evidence-based guidelines. Health Care Management Review. 37(1). 67–76. 29 indexed citations
13.
Mele, Valentina & Amelia Compagni. (2010). EXPLAINING THE UNEXPECTED SUCCESS OF THE SMOKING BAN IN ITALY: POLITICAL STRATEGY AND TRANSITION TO PRACTICE, 2000-2005. Public Administration. 88(3). 819–835. 9 indexed citations
14.
Compagni, Amelia, et al.. (2008). Avoiding adverse drug reactions by pharmacogenetic testing: A systematic review of the economic evidence in the case of TPMT and AZA-induced side effects. International Journal of Technology Assessment in Health Care. 24(3). 294–302. 21 indexed citations
15.
Compagni, Amelia, et al.. (2008). Orphan drug legislation: lessons for neglected tropical diseases. The International Journal of Health Planning and Management. 24(1). 27–42. 40 indexed citations
16.
Compagni, Amelia, Laura Cavalli, & Claudio Jommi. (2008). Pharmaceutical companies and Italian Regional Governments: Managing relationships in an increasing institutional complexity. Health Policy. 87(3). 333–341. 3 indexed citations
17.
Carroll, Christopher, Ronald W. Manderscheid, Allen S. Daniels, & Amelia Compagni. (2006). Convergence of service, policy, and science toward consumer-driven mental health care.. PubMed. 9(4). 185–92. 4 indexed citations
18.
Turner, Christopher J., Susanne Adams, Amelia Compagni, et al.. (2006). Ephrin-B2 Controls Cell Motility and Adhesion during Blood-Vessel-Wall Assembly. Cell. 124(1). 161–173. 357 indexed citations
19.
Compagni, Amelia, Malcolm Logan, Rüdiger Klein, & Ralf H. Adams. (2003). Control of Skeletal Patterning by EphrinB1-EphB Interactions. Developmental Cell. 5(2). 217–230. 187 indexed citations
20.
Bunone, Giuseppe, Agnese Mariotti, Amelia Compagni, Elena Morandi, & Giuliano Della Valle. (1997). Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells. Oncogene. 14(12). 1463–1470. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zubin Master Breakdown of academic impact, for papers by Paul D. Crowe Breakdown of academic impact, for papers by Fiona Murray Breakdown of academic impact, for papers by Sandra Davis Breakdown of academic impact, for papers by Pauline Wong Breakdown of academic impact, for papers by Hong Ping Zhang Breakdown of academic impact, for papers by Robin Roberts Breakdown of academic impact, for papers by Qingjie Xia Breakdown of academic impact, for papers by David P. Cook Breakdown of academic impact, for papers by Yong‐Man Kim
Rankless by CCL
2026